Enveric Biosciences
ENVB
ENVB
24 hedge funds and large institutions have $1.99M invested in Enveric Biosciences in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
45% less capital invested
Capital invested by funds: $3.61M → $1.99M (-$1.62M)
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
Holders
24
Holding in Top 10
–
Calls
$12K
Puts
$3K
Top Buyers
| 1 | +$70.6K | |
| 2 | +$49K | |
| 3 | +$8.03K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.58K |
| 5 |
V
Veritable
Wilmington,
Delaware
|
+$4K |
Top Sellers
| 1 | -$193K | |
| 2 | -$94K | |
| 3 | -$58K | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$43K |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$42.9K |